What Base Molecular Resonance Technologies does

Base Molecular Resonance Technologies (BMRT) is a privately held, Stuart, Florida-based detection technology company that has developed the Base Molecular Resonance (BMR™) platform, a multi-patented quantum physics-based system that identifies materials, substances, and biological threats by reading molecular resonance signatures at the subatomic level rather than relying on radar, RF, or thermal imaging. The platform claims to detect every element on the periodic table and up to 200 types of cancers and diseases, with 100% accuracy and no false positives or negatives validated by an independent study from York St John University's Centre for Applied Innovation. BMRT has demonstrated the technology in U.S. Department of War Combatant Command-sponsored multi-day testing, achieving 100% accurate concealed-target detection at distances up to 20 km, detection through steel-and-concrete shielding five stories underground, mobile in-motion detection, and in a Generation 2 maritime demonstration detecting U-235 nuclear material at nearly 970 miles, nitrocellulose-based propellant at 1,500 feet, and trace signatures from a vessel at 270 feet.

The company monetizes primarily through IP licensing — its portfolio has been independently valued at $60.3 billion across 56 global use cases and $1.8 billion for the U.S. security vertical by ipCapital Group — supplemented by technology deployment and integration through strategic partnerships. Its go-to-market combines enterprise field sales to U.S. government and military commands, government-sponsored demonstration events at national testing facilities, and channel partnerships including a Tough Stump Technologies alliance for a Department of War initiative and a non-binding SafeSpace Global joint venture LOI targeting 130,000+ U.S. schools and 5,000 correctional facilities. BMRT serves security and public safety, medical and healthcare, military and defense, and industrial and research customers through a horizontal segmentation approach, and operates a wholly-owned subsidiary, BMRT Security, Inc., launched in February 2025 with a $15 million investment initiative. To date the company has raised approximately $8 million in disclosed funding, holds 20 granted patents with dozens more in development, and has built a leadership bench that includes a former Director of the U.S. Marshals Service, a former Assistant Attorney General for the Office of Justice Programs, and a former Special Agent in Charge of the U.S. Secret Service Presidential Protective Division on its Board of Advisors.

Name

Base Molecular Resonance Technologies

Legal name

Base Molecular Resonance Technologies Holding LLC

Website

https://bmrt.io

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

11–50 employees

Short description

Base Molecular Resonance Technologies (BMRT) develops a patented quantum physics-based detection platform that identifies materials, threats, cancers, and diseases by their molecular resonance signatures with 100% validated accuracy. The Stuart, Florida company licenses and deploys BMR™ technology across security, military, medical, and industrial customers.

Ownership category

akta.pro rank

Product category

Quantum Detection Systems

NAICS

Irradiation Apparatus Manufacturing (334517), Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)

SIC

Search, Detection, Navagation, Guidance, Aeronautical Sys (3812), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)

akta.pro primary industry

CBRN Detection, Protection & Decontamination Systems (IMABAOAO)

akta.pro secondary industries

Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

Keywords

• Quantum detection systems
• Molecular resonance sensors
• Security screening technology
• Explosives detection devices
• Medical diagnostic sensors

Headquarters

HQ city

Stuart

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

1. IP Licensing: BMRT's primary revenue model centers on licensing its patented technology portfolio. The company has received independent IP valuations of $60.3 billion across 56 global use cases and $1.8 billion for US security sector alone, indicating significant licensing potential to third parties across security, medical, defense, and other verticals.
2. Technology Deployment and Integration: Revenue generated through deployment and integration of BMR technology into customer-specific applications, such as the joint venture with SafeSpace Global for school and correctional facility deployment targeting over 130,000 schools and 5,000 facilities.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

BMRT develops and licenses multi-patented Base Molecular Resonance (BMR™) detection systems that identify materials, substances, biological threats, and diseases by detecting molecular resonance characteristics at the subatomic level. The technology provides instant, non-invasive detection of every element on the periodic table and up to 200 types of cancers and diseases, validated with 100% accuracy and no false positives or negatives in independent third-party studies. The platform is delivered to enterprise and government customers via direct sales, technology deployment, and IP licensing arrangements.

Product overview

Base Molecular Resonance Technologies (BMRT) offers a unified quantum physics-based detection platform centered on its patented Base Molecular Resonance (BMR™) technology. The core platform detects every element on the periodic table, up to 200 types of cancers and diseases, and various threats through molecular resonance signatures. The product portfolio includes the current Generation 2 Maritime Detection Platform for maritime and long-range applications, with Generation 3 in development for enhanced precision and standoff distance. BMRT Security, Inc. serves as the company's security-focused subsidiary. Key capabilities span counter-drone detection, fentanyl detection, and DNA signature detection, all leveraging the same foundational BMR™ platform technology validated with 20 patents and 100% accuracy in independent testing.

Differentiator

Problem solved

Functional benefit

Products and services

• Base Molecular Resonance (BMR™) Technology Platform Multi-patented quantum physics-based detection platform that identifies materials, substances, and biological threats instantly, at distance, and through barriers by detecting molecular resonance signatures. Sold/licensed to government agencies, defense contractors, healthcare providers, and security integrators.
• Generation 2 Maritime Detection Platform Advanced maritime and long-range detection system for naval, defense, and homeland security customers, capable of detecting explosives, propellants, and nuclear materials from offshore vessels and underwater targets at standoff distances up to nearly 970 miles.

Quantifiable outcome

• 100% accurate detection of concealed targets at distances up to 20km
• +5 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Tough Stump TechnologiescoreStrategic or Co-development Partner · 18 May 2026BMRT has been formally engaged by Tough Stump Technologies as a critical technology partner in support of a global strategic initiative at the highest levels of the Department of War, focused on mission-critical capabilities to address emerging threats from advanced adversaries. Both companies view this partnership as the foundation for future strategic efforts in national security and defense solutions, with complementary technologies aimed at delivering transformational advantages for the modern battlefield.
• SafeSpace GlobalcoreStrategic or Co-development Partner · 18 December 2025SafeSpace Global entered a non-binding Letter of Intent with BMRT to develop a joint venture for deploying molecular-level weapons detection technology in U.S. schools and correctional facilities. The deployment aims to cover over 130,000 schools and 5,000 correctional facilities, with pilot programs expected to start in mid-2026. This represents an estimated $6 billion addressable market.
• York St John UniversitycoreTechnology or IntegrationYork St John University's Centre for Applied Innovation conducted validation work for BMRT's detection technology. Professor Philippe B. Wilson, Associate Pro Vice-Chancellor for Innovation and Knowledge Exchange and Director of the Centre for Applied Innovation, provided third-party assessment and evaluation of the BMRT technology, confirming 100% accuracy with no false positives or negatives.
• Second Opinion ExpertminorStrategic or Co-development PartnerStrategic relationship agreement with Second Opinion Expert to leverage their extensive expertise in the healthcare industry as BMRT deploys its technology in the medical sector. BMRT's Co-Founder and CEO Bo Short stated they are honored to work with SOE, leveraging their healthcare industry expertise and robust capabilities.

Scale indicators9 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Nuctech: Nuctech provides security inspection technology including radiation and CBRN detection for customs, airports, and government, overlapping with BMRT's threat detection portfolio.
• Smiths Detection: Smiths Detection manufactures CBRN and explosives detection systems for airports, customs, military, and critical infrastructure, directly competing with BMRT's core security vertical across similar customer segments.
• Rapiscan Systems: Rapiscan (an OSI Systems company) provides security screening and threat detection for aviation, ports, and government, overlapping with BMRT's concealed-threat and counter-weapons detection use cases.
• Mirion Technologies: Mirion specializes in radiation and nuclear material detection for defense, nuclear power, and medical markets, directly comparable to BMRT's U-235 and CBRN detection capabilities.
• 908 Devices: 908 Devices makes mass spectrometry-based detection tools for CBRN, forensics, and life sciences, comparable to BMRT in targeting defense and security customers with advanced detection hardware.

Broad incumbents

• FLIR Systems (Teledyne FLIR): Teledyne FLIR (formerly FLIR Systems) offers a broad portfolio of thermal imaging and detection systems for defense, industrial, and security markets, with overlapping but more mature capabilities than BMRT's emerging platform.
• L3Harris Technologies: L3Harris is a large defense prime with detection, electronic warfare, and surveillance capabilities, comparable as a broad incumbent that could either partner with or compete against BMRT in defense detection programs.

Emerging players

• RedWave Technology: RedWave develops IR spectroscopy-based chemical and threat detection for defense and industrial safety, an emerging competitor in the molecular detection space adjacent to BMRT's resonance approach.
• BlueHalo: BlueHalo is a defense technology integrator with counter-drone and directed-energy capabilities, overlapping with BMRT's emerging counter-UAS detection positioning for DoD customers.

Others

• Battelle Memorial Institute: Battelle conducts national security R&D and CBRN defense work for federal clients; an ecosystem participant and prior employer of BMRT board advisor Regina Schofield, comparable as a defense-research counterpart rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/livenowfox
• YouTubeyoutube.com/channel/UCd5RdM5GcB1e6sC62L5M8MA
• LinkedInlinkedin.com/company/bmrt
• Facebookfacebook.com/people/Base-Molecular-Resonance-Technologies-BMRT/61553924976436
• Instagraminstagram.com/base.molecular.resonance

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Base Molecular Resonance Technologies